Invasive Fungal Infections in Low-Risk Liver Transplant Recipients: A Multi-Center Prospective Observational Study
dc.contributor.author | Pappas, Peter G. | en_US |
dc.contributor.author | Andes, D. | en_US |
dc.contributor.author | Schuster, M. | en_US |
dc.contributor.author | Hadley, S. | en_US |
dc.contributor.author | Rabkin, John M. | en_US |
dc.contributor.author | Merion, Robert M. | en_US |
dc.contributor.author | Kauffman, C. A. | en_US |
dc.contributor.author | Huckabee, C. | en_US |
dc.contributor.author | Cloud, Gretchen A. | en_US |
dc.contributor.author | Dismukes, William E. | en_US |
dc.contributor.author | Karchmer, A. W. | en_US |
dc.date.accessioned | 2010-06-01T21:01:10Z | |
dc.date.available | 2010-06-01T21:01:10Z | |
dc.date.issued | 2006-02 | en_US |
dc.identifier.citation | Pappas, P. G.; Andes, D.; Schuster, M.; Hadley, S.; Rabkin, J.; Merion, R. M.; Kauffman, C. A.; Huckabee, C.; Cloud, G. A.; Dismukes, W. E.; Karchmer, A. W. (2006). "Invasive Fungal Infections in Low-Risk Liver Transplant Recipients: A Multi-Center Prospective Observational Study." American Journal of Transplantation 6(2): 386-391. <http://hdl.handle.net/2027.42/74111> | en_US |
dc.identifier.issn | 1600-6135 | en_US |
dc.identifier.issn | 1600-6143 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/74111 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16426325&dopt=citation | en_US |
dc.format.extent | 188171 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Munksgaard International Publishers | en_US |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 2006 The American Society of Transplantation and the American Society of Transplant Surgeons | en_US |
dc.subject.other | Antifungal | en_US |
dc.subject.other | Fungal Infections | en_US |
dc.subject.other | Invasive Candidiasis | en_US |
dc.subject.other | Liver Transplant Recipients | en_US |
dc.subject.other | Prophylaxis | en_US |
dc.title | Invasive Fungal Infections in Low-Risk Liver Transplant Recipients: A Multi-Center Prospective Observational Study | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan Medical Center, Ann Arbor, MI | en_US |
dc.contributor.affiliationother | University of Alabama at Birmingham Medical Center | en_US |
dc.contributor.affiliationother | University of Wisconsin Health Sciences Center, Madison, WI | en_US |
dc.contributor.affiliationother | University of Pennsylvania Medical Center, Philadelphia, PA | en_US |
dc.contributor.affiliationother | New England – Tufts Medical Center, Boston, MA | en_US |
dc.contributor.affiliationother | University of Oregon Health Sciences Center, Portland, OR | en_US |
dc.contributor.affiliationother | Rho Incorporated, Chapel Hill, NC | en_US |
dc.contributor.affiliationother | Beth Israel-Deaconess Medical Center, Boston, MA | en_US |
dc.identifier.pmid | 16426325 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/74111/1/j.1600-6143.2005.01176.x.pdf | |
dc.identifier.doi | 10.1111/j.1600-6143.2005.01176.x | en_US |
dc.identifier.source | American Journal of Transplantation | en_US |
dc.identifier.citedreference | Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993; 16: 677 – 688. | en_US |
dc.identifier.citedreference | Castaldo P, Stratta RJ, Wood P et al. Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg 1991; 126: 149 – 156. | en_US |
dc.identifier.citedreference | Wajszczuk CP, Dummer JS, Ho M et al. Fungal infections in liver transplant recipients. Transplantation 1985; 40: 347 – 353. | en_US |
dc.identifier.citedreference | Kusne S, Dummer JS, Singh N et al. Infections after liver transplantation. Medicine 1988; 67: 132 – 143. | en_US |
dc.identifier.citedreference | Hadley S, Samore MH, Lewis WD, Jenkins RL, Karchmer AW, Hammer SM. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Transplantation 1995; 59: 851 – 859. | en_US |
dc.identifier.citedreference | Husain S, Tollemar J, Dominguez EA et al. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation 2003; 75: 2023 – 2029. | en_US |
dc.identifier.citedreference | Singh N, Gayowski T, Wagener MM, Doyle H, Marino IR. Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. Clin Infect Dis 1997; 24: 179 – 184. | en_US |
dc.identifier.citedreference | Singh N, Avery RK, Munoz P et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 2003; 36: 46 – 52. | en_US |
dc.identifier.citedreference | Patel R, Portela D, Badley A et al. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. Transplantation 1996; 62: 926 – 934. | en_US |
dc.identifier.citedreference | Viviani MA, Tortorano AM, Malaspina C et al. Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis. Eur J Epidemiol 1992; 8: 433 – 436. | en_US |
dc.identifier.citedreference | Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995; 21: 1328 – 1336. | en_US |
dc.identifier.citedreference | Collins LA, Samore MH, Roberts MS et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis 1994; 170: 644 – 652. | en_US |
dc.identifier.citedreference | Karchmer AW, Samore MH, Hadley S, Collins LA, Jenkins L, Lewis WD. Fungal infections complicating orthotopic liver transplantation. Trans Am Clin Climatol Assoc 1995; 106: 38 – 48. | en_US |
dc.identifier.citedreference | Hadley S, Karchmer AW. Fungal infections in solid organ transplant recipients. Infect Transplant 1995; 9: 1045 – 1074. | en_US |
dc.identifier.citedreference | Briegel J, Forst H, Spill B et al. Risk factors for systemic fungal infections in liver transplant recipients. Eur J Clin Microbiol Infect Dis 1995; 14: 375 – 382. | en_US |
dc.identifier.citedreference | Rabkin JM, Oroloff SL, Corless CL et al. Association of fungal infection and increased mortality in liver transplant recipients. Am J Surg 2000; 179: 427 – 430. | en_US |
dc.identifier.citedreference | Biancofiore G, Bindi ML, Baldassarri R et al. Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study. Transpl Int 2002; 15: 341 – 374. | en_US |
dc.identifier.citedreference | Braun F, RÜchel R, Lorf R et al. Is liposomal amphotericin B (Ambisome) an effective prophylaxis of mycotic infections after liver transplantation? Transplant Proc 1998; 30: 1481 – 1483. | en_US |
dc.identifier.citedreference | Fisher NC, Singhal S, Miller SJ, Hastings JGM, Mutimer DJ. Fungal infection and liposomal amphotericin B (AmBisome) therapy in liver transplantation: a 2 year review. J Antimicrob Chemother 1999; 43: 597 – 600. | en_US |
dc.identifier.citedreference | Fortun J, Martin-Davila P, Moreno S et al. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin in high-risk patients. J Antimicrob Chemother 2003; 52: 813 – 819. | en_US |
dc.identifier.citedreference | Lumbreras C, Cuervas-Mons V, Jara P et al. Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.. J Infect Dis 1996; 174: 583 – 588. | en_US |
dc.identifier.citedreference | Mora NP, Klintmalm G, Solomon G, Goldstein RM, Gonwa TA, Husberg BS. Selective amphotericin B prophylaxis in the reduction of fungal infections after liver transplant. Transplant Proc 1992; 24: 154 – 155. | en_US |
dc.identifier.citedreference | Sharpe MD, Ghent C, Grant C, Horbay GLA, McDougal J, Colby WD. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study. Transplantation 2003; 76: 977 – 983. | en_US |
dc.identifier.citedreference | Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR. Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy. Transplantation 2001; 71: 910 – 913. | en_US |
dc.identifier.citedreference | Tollemar J, Hockerstedt K, Ericzon BG, Jalanko H, RingdÈn O. Prophylaxis with liposomal amphotericin B (AmBisome) prevents fungal infections in liver transplant recipients: long-term results of a randomized, placebo-controlled trial. Transplant Proc 1995; 27: 1195 – 1198. | en_US |
dc.identifier.citedreference | Winston DJ, Pakrasi A, Busuttil RW. Prophylactic fluconazole in liver transplant recipients: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999; 131: 729 – 737. | en_US |
dc.identifier.citedreference | Winston DJ, Busuttil RW. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients. Transplantation 2002; 74: 688 – 695. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.